Biofrontera (BFRI) Earnings Date & Reports

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BFRI is expected to report earnings to fall 21.43% to -21 cents per share on August 11

Q2'23

Est.

$-0.22

Q1'23

Missed

by $0.20

Q4'22

Missed

by $0.04

Q3'22

Beat

by $0.18

Q2'22

Beat

by $0.29

The last earnings report on May 12 showed earnings per share of -28 cents, missing the estimate of -7 cents. With 18.96K shares outstanding, the current market capitalization sits at 9.77M.

View a ticker or compare two or three

Compare

BFRI